Clinical Trial Update: Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing gemcitabine alone versus gemcitabine with sorafenib in locally advanced or metastatic pancreatic cancer. The current status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Nexavar (Sorafenib)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN